🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07436910
Enrolling by invitation Observational

Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease

NCT07436910 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-09-01
Last updated
2026-02-27

Condition(s) studied

Irritable Bowel DiseaseUlcerative Colitis (UC)Crohn Disease (CD)

Study summary

The primary aim of this study is to assess HRQOL and its associated factors among people with IBD. The target sample will be 385 adult patients diagnosed with IBD (both Crohn's Disease and Ulcerative Colitis). The data will be collected using a self-administered survey.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years or older. * Have a confirmed diagnosis of IBD. * Can understand and complete the study questionnaires. * Provide written informed consent to participate in the study. Exclusion Criteria: * Have a diagnosis of indeterminate colitis. * Have any other chronic inflammatory conditions. * Have severe cognitive impairment that hinders their ability to complete the questionnaires.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cairo University Cairo Egypt

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07436910 on ClinicalTrials.gov ↗ ← All trials in Egypt